Infex appoints Lonza to manufacture new lung infection drug
Alderley Park, Cheshire Infex Therapeutics has awarded a £1m contract to Lonza…
Deals agreed as Infex’s resistance bypass drug program heads for clinic
Alderley Park, Cheshire Infex Therapeutics has appointed Pharmaron to help…
Infex focuses on pandemic preparedness with Covid patent
Infex Therapeutics has filed for a UK patent for a novel therapy designed to…
Infex Therapeutics and LifeArc in Collaboration to Defeat Superbugs
Infex Therapeutics has combined forces with medical research charity, LifeArc,…
Major boost in global fight against antimicrobial resistance as AMR Centre receives share of Strength in Places Fund award
The AMR Centre has combined forces to attract much needed investment to…
The AMR Centre signs agreement to co-develop treatment for gonorrhoea
The AMR Centre (AMRC) has today announced a multi-year co-development…
A Deal to Fix the Broken Antibiotic Market?
The market for new antibiotics is effectively failing. No novel class of drugs…
BioTrinity, 28-29th April 2020
London Link: biotrinity.com We’re attending BioTrinity 2020 in London,…
More People in the United States Dying from Antibiotic-Resistant Infections than Previously Estimated
Significant progress since 2013 could be lost without more action The…